OBJECTIVE To evaluate trends of monozygotic twinning after single embryo transfer and its association with patient and treatment factors. METHODS Our retrospective cohort study included 28,596 pregnancies after fresh, nondonor single embryo transfer during 2003–2012 reported to the National ART Surveillance System. We examined trends of monozygotic twin pregnancies (number of fetal heart tones on first-trimester ultrasonography more than one or number of neonates born more than one) and assessed patient and treatment factors for monozygotic twin compared with singleton pregnancies. Modified Poisson regression models were used to estimate adjusted risk ratios (RRs) and 95% confidence intervals (CIs) for association between monozygotic twinning and selected factors stratified by day 2–3 and day 5–6 transfer. RESULTS During 2003–2012, the incidence of monozygotic twinning after single embryo transfer was lower for day 2–3 transfers than for day 5–6 transfers (1.71%, 95% CI 1.45–1.98, n=162 compared with 2.50%, 95% CI 2.28–2.73, n=472); the incidence did not change significantly over the study period. Among day 2–3 transfers, assisted hatching increased the risk for monozygotic twinning compared with singletons (adjusted RR 2.16, 95% CI 1.53–3.06); use of intracytoplasmic sperm injection decreased the risk (adjusted RR 0.60, 95% CI 0.42–0.85). Having one or more prior pregnancies increased the risk for monozygotic twinning among day 5–6 transfers (adjusted RR 1.26, 95% CI 1.03–1.53). CONCLUSION Monozygotic twinning after single embryo transfers was more common among day 5–6 embryo transfers than day 2–3 transfers. Use of assisted hatching was associated with increased risk for monozygotic twinning for day 2–3 transfers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.